Animal fats firm Synthase Biotech goes bust owing $3.5m
Subscribe to BusinessDesk
Stay informed on business, government and financial developments across New Zealand.
- Deeply researched, twice-edited and fact-checked news
- Annual subscribers also receive a complimentary subscription to The Wall Street Journal
- Personalised email news alerts, plus gift up to 5 stories a month to non-subscribers
You can cancel anytime with two clicks, an email or a phone call.
Find out more.
We are serious about journalism.
Already a Subscriber ? Sign in here.
All subscriptions auto renew but are easy to cancel.
Total Price Including Tax: {{ priceWithTax(selectedPlan) | currency }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerSeat ? '/ '+ spark.seatName : '' }} {{ selectedPlan.type == 'user' && spark.chargesUsersPerTeam ? '/ '+ __('teams.team') : '' }} / {{ __(selectedPlan.interval) | capitalize }}
Not convinced yet?
Subscribe to our free 7am Headlines newsletter.
A quick summary of everything BusinessDesk has published in the previous 24 hours. No BusinessDesk
subscription needed.
NZ sharemarket starts week down 0.8%
The S&P/NZX 50 Index closed at 13,351.92, down 115.34 points or 0.86%.
Du Val pair ordered to pay costs
The Clarkes are to pay the markets regulator following the asset seizure hearing.
Auckland developer collapse leaves $40m in debt
Between all firms, debts with the IRD are about $25 million.
The risks of powering New Zealand’s data boom
Sydney has curbed data centres to save power and water. Can New Zealand plan more wisely?
